Genomic Health, Inc.
GHDX
GHDX was delisted on the 7th of November, 2019.
132 hedge funds and large institutions have $1.04B invested in Genomic Health, Inc. in 2015 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 36 increasing their positions, 44 reducing their positions, and 9 closing their positions.
3,634% more call options, than puts
Call options by funds: $1.75M | Put options by funds: $47K
189% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 9
62% more capital invested
Capital invested by funds: $644M → $1.04B (+$397M)
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
13% more funds holding
Funds holding: 117 → 132 (+15)
18% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 44
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$8.37M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$4.64M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$3.52M |
| 4 |
Two Sigma Investments
New York
|
+$2.68M |
| 5 |
ZDA
Zweig-DiMenna Associates
New York
|
+$2.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$20.5M |
| 2 |
ICM
IronBridge Capital Management
Oakbrook Terrace,
Illinois
|
-$9.2M |
| 3 |
DM
Deerfield Management
New York
|
-$7.61M |
| 4 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$3.25M |
| 5 |
Morgan Stanley
New York
|
-$2.44M |
GHDX Hedge Fund Activity: Q4 2015 in Review
132 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q4 2015, worth a combined $1.04B — up 62% from $644M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new GHDX positions and 9 closed out — a net gain of 17 holders — while 36 added to existing stakes and 44 trimmed.
The largest buyer was Millennium Management, adding an estimated $8.37M. The largest seller was State Street, cutting an estimated $20.5M.
- 132 institutional investors held Genomic Health, Inc. (GHDX) as of Q4 2015, up from 117 in Q3 2015.
- Funds reported $1.04B of Genomic Health, Inc. stock for Q4 2015, up 62% quarter-over-quarter.
- 26 funds opened new Genomic Health, Inc. positions in Q4 2015 and 9 closed out, a net change of +17 holders.
- The largest Genomic Health, Inc. buyer in Q4 2015 was Millennium Management, an estimated $8.37M added.
- The largest Genomic Health, Inc. seller in Q4 2015 was State Street, an estimated $20.5M sold.
Based on aggregated 13F filings for Q4 2015.